home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  April 26, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries

AceProbe Technologies (India) Pvt. ltd

Fort Floor, Block No. C2, Plot No. 296, Janakpuri
New Delhi
India

Phone: +91-11-45523373
Fax: +91-11-25524000

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Stock symbol: APTIN
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

A FALLOUT OF NASDAQ COMPANY IN INDIA-

AceProbe has evolved with a team of Biotech professionals and operates in the niche area of genomics that enable our partners to efficiently design and perform experiments, monitor progress, receive and interpret results, and making the adoption of technology in a trivial manner. By partnering with AceProbe, scientists can rapidly discover complex connections between genetic profiles, disease risk and therapeutic response, with ease.

Our comprehensive Technology Platform and System offerings allow access to a multitude of clinical and research data, key analysis modules for both genotype and expression information, and database archiving and processing capabilities. Flexible platform and custom service features for a medium-density, ultra-high-throughput, customizable format make all its offerings unique with unmatched credentials and allows researchers to stratify patient populations prior to conducting clinical trials. Because it uniquely characterizes individuals' responses to specific medications, our partners :

Streamline the drug development process

Reduce development costs

Optimize dosage and increase safety

Increase the chances of success in clinical trials

Extend and Build ropbust, product life and intellectual property opportunities.


Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Agriculture
Diagnostics
- in vitro
- Medical
Supplier
- Laboratory
Contract
- Research
Laboratory
- Analytical

Last update of this entry: August 15, 2018

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.